{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T14:39:55Z","timestamp":1778596795698,"version":"3.51.4"},"reference-count":52,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100011635","name":"Chinese Academy of Medical Sciences & Peking Union Medical College Fuwai Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011635","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmcd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.numecd.2023.07.010","type":"journal-article","created":{"date-parts":[[2023,7,19]],"date-time":"2023-07-19T02:57:58Z","timestamp":1689735478000},"page":"2151-2159","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["The causal associations of non-alcoholic fatty liver disease with blood pressure and the mediating effects of cardiometabolic risk factors: A Mendelian randomization study"],"prefix":"10.1016","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6048-6610","authenticated-orcid":false,"given":"Zhuxin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Le","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Likun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenhao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yulong","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.numecd.2023.07.010_bib1","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.numecd.2023.07.010_bib2","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1111\/liv.14828","article-title":"Prevalence of NAFLD, MAFLD and associated advanced fibrosis in the contemporary United States population","volume":"41","author":"Ciardullo","year":"2021","journal-title":"Liver Int"},{"key":"10.1016\/j.numecd.2023.07.010_bib3","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1136\/gutjnl-2020-320622","article-title":"NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications","volume":"69","author":"Targher","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.numecd.2023.07.010_bib4","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1097\/MEG.0b013e32834b8d52","article-title":"Nonalcoholic fatty liver disease is associated with blood pressure in hypertensive and nonhypertensive individuals from the general population with normal levels of alanine aminotransferase","volume":"23","author":"L\u00f3pez-Su\u00e1rez","year":"2011","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.numecd.2023.07.010_bib5","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1097\/HJH.0000000000000445","article-title":"The association of nonalcoholic fatty liver disease with central and peripheral blood pressure in adolescence: findings from a cross-sectional study","volume":"33","author":"Patel","year":"2015","journal-title":"J Hypertens"},{"key":"10.1016\/j.numecd.2023.07.010_bib6","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/HJH.0000000000001204","article-title":"Gamma-glutamyltransferase, fatty liver index and hepatic insulin resistance are associated with incident hypertension in two longitudinal studies","volume":"35","author":"Bonnet","year":"2017","journal-title":"J Hypertens"},{"key":"10.1016\/j.numecd.2023.07.010_bib7","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1111\/jgh.12643","article-title":"Clinical association between non-alcoholic fatty liver disease and the development of hypertension","volume":"29","author":"Ryoo","year":"2014","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.numecd.2023.07.010_bib8","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.jhep.2014.01.009","article-title":"Development of new fatty liver, or resolution of existing fatty liver, over five years of follow-up, and risk of incident hypertension","volume":"60","author":"Sung","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.numecd.2023.07.010_bib9","article-title":"Early-life cardiovascular risk factor trajectories and vascular aging in midlife: a 30-year prospective cohort study","volume":"122","author":"Wang","year":"2023","journal-title":"Hypertension"},{"key":"10.1016\/j.numecd.2023.07.010_bib10","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1067\/mhj.2001.113069","article-title":"Do conventional risk factors predict subclinical coronary artery disease? Results from the Prospective Army Coronary Calcium Project","volume":"141","author":"Taylor","year":"2001","journal-title":"Am Heart J"},{"key":"10.1016\/j.numecd.2023.07.010_bib11","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1001\/jamacardio.2020.1731","article-title":"Association of normal systolic blood pressure level with cardiovascular disease in the absence of risk factors","volume":"5","author":"Whelton","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.numecd.2023.07.010_bib12","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.socscimed.2017.12.005","article-title":"Understanding and misunderstanding randomized controlled trials","volume":"210","author":"Deaton","year":"2018","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.numecd.2023.07.010_bib13","first-page":"962","article-title":"Commentary: Mendelian randomization-inspired causal inference in the absence of genetic data","volume":"46","author":"Zuccolo","year":"2017","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.numecd.2023.07.010_bib14","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/gepi.21758","article-title":"Mendelian randomization analysis with multiple genetic variants using summarized data","volume":"37","author":"Burgess","year":"2013","journal-title":"Genet Epidemiol"},{"key":"10.1016\/j.numecd.2023.07.010_bib15","doi-asserted-by":"crossref","first-page":"k601","DOI":"10.1136\/bmj.k601","article-title":"Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians","author":"Davies","year":"2018","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.numecd.2023.07.010_bib16","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/s41588-022-01078-z","article-title":"A trans-ancestry genome-wide association study of unexplained chronic ALT elevation as a proxy for nonalcoholic fatty liver disease with histological and radiological validation","volume":"54","author":"Vujkovic","year":"2022","journal-title":"Nat Genet"},{"key":"10.1016\/j.numecd.2023.07.010_bib17","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1038\/s41588-018-0205-x","article-title":"Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits","volume":"50","author":"Evangelou","year":"2018","journal-title":"Nat Genet"},{"key":"10.1016\/j.numecd.2023.07.010_bib18","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/gepi.21998","article-title":"Bias due to participant overlap in two-sample Mendelian randomization","volume":"40","author":"Burgess","year":"2016","journal-title":"Genet Epidemiol"},{"key":"10.1016\/j.numecd.2023.07.010_bib19","series-title":"Orienting the causal relationship between imprecisely measured traits using GWAS summary data","author":"G H","year":"2017"},{"key":"10.1016\/j.numecd.2023.07.010_bib20","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1093\/aje\/kwt084","article-title":"Efficient design for Mendelian randomization studies: subsample and 2-sample instrumental variable estimators","volume":"178","author":"Pierce","year":"2013","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.numecd.2023.07.010_bib21","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression","volume":"44","author":"Bowden","year":"2015","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.numecd.2023.07.010_bib22","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/EDE.0000000000000559","article-title":"Sensitivity analyses for robust causal inference from mendelian randomization analyses with multiple genetic variants","volume":"28","author":"Burgess","year":"2017","journal-title":"Epidemiology"},{"key":"10.1016\/j.numecd.2023.07.010_bib23","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/gepi.21965","article-title":"Consistent estimation in mendelian randomization with some invalid instruments using a weighted median estimator","volume":"40","author":"Bowden","year":"2016","journal-title":"Genet Epidemiol"},{"key":"10.1016\/j.numecd.2023.07.010_bib24","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1214\/19-AOS1866","article-title":"Statistical inference in two-sample summary-data Mendelian randomization using robust adjusted profile score","volume":"48","author":"Zhao","year":"2020","journal-title":"Ann Stat"},{"key":"10.1016\/j.numecd.2023.07.010_bib25","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.ajhg.2021.05.014","article-title":"Constrained maximum likelihood-based Mendelian randomization robust to both correlated and uncorrelated pleiotropic effects","volume":"108","author":"Xue","year":"2021","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.numecd.2023.07.010_bib26","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1002\/sim.7221","article-title":"A framework for the investigation of pleiotropy in two-sample summary data Mendelian randomization","volume":"36","author":"Bowden","year":"2017","journal-title":"Stat Med"},{"key":"10.1016\/j.numecd.2023.07.010_bib27","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10654-017-0255-x","article-title":"Interpreting findings from Mendelian randomization using the MR-Egger method","volume":"32","author":"Burgess","year":"2017","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.numecd.2023.07.010_bib28","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/ije\/dyr233","article-title":"Two-step epigenetic Mendelian randomization: a strategy for establishing the causal role of epigenetic processes in pathways to disease","volume":"41","author":"Relton","year":"2012","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.numecd.2023.07.010_bib29","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1093\/ije\/dyu176","article-title":"The EPIC-InterAct Consortium. Network Mendelian randomization: using genetic variants as instrumental variables to investigate mediation in causal pathways","volume":"44","author":"Burgess","year":"2015","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.numecd.2023.07.010_bib30","doi-asserted-by":"crossref","first-page":"186","DOI":"10.12688\/wellcomeopenres.15555.1","article-title":"Guidelines for performing Mendelian randomization investigations","volume":"4","author":"Burgess","year":"2019","journal-title":"Wellcome Open Res"},{"key":"10.1016\/j.numecd.2023.07.010_bib31","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jhep.2016.05.013","article-title":"Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis","volume":"65","author":"Targher","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.numecd.2023.07.010_bib32","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1097\/HJH.0000000000001245","article-title":"Association between MRI-derived hepatic fat fraction and blood pressure in participants without history of cardiovascular disease","volume":"35","author":"Lorbeer","year":"2017","journal-title":"J Hypertens"},{"key":"10.1016\/j.numecd.2023.07.010_bib33","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/MEG.0000000000002299","article-title":"Nonalcoholic fatty liver disease and risk of incident hypertension: a systematic review and meta-analysis","volume":"34","author":"Ciardullo","year":"2022","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.numecd.2023.07.010_bib34","doi-asserted-by":"crossref","first-page":"458","DOI":"10.5152\/tjg.2021.20641","article-title":"Systolic blood pressure mediates body mass index and non-alcoholic fatty liver disease: a population-based study","volume":"32","author":"Guan","year":"2021","journal-title":"Turk J Gastroenterol"},{"key":"10.1016\/j.numecd.2023.07.010_bib35","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1080\/10641963.2016.1182181","article-title":"Gender impacts on the correlations between nonalcoholic fatty liver disease and hypertension in a Chinese population aged 45\u201360 y","volume":"38","author":"Li","year":"2016","journal-title":"Clin Exp Hypertens"},{"key":"10.1016\/j.numecd.2023.07.010_bib36","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1093\/bioinformatics\/btw373","article-title":"PhenoScanner: a database of human genotype-phenotype associations","volume":"32","author":"Staley","year":"2016","journal-title":"Bioinformatics"},{"key":"10.1016\/j.numecd.2023.07.010_bib37","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/s41580-018-0044-8","article-title":"Metabolites as regulators of insulin sensitivity and metabolism","volume":"19","author":"Yang","year":"2018","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.numecd.2023.07.010_bib38","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.jhep.2006.02.011","article-title":"Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2","volume":"44","author":"Haukeland","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.numecd.2023.07.010_bib39","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1210\/er.2019-00034","article-title":"The liver as an endocrine organ\u2014linking NAFLD and insulin resistance","volume":"40","author":"Watt","year":"2019","journal-title":"Endocr Rev"},{"key":"10.1016\/j.numecd.2023.07.010_bib40","doi-asserted-by":"crossref","first-page":"21630","DOI":"10.1002\/jcp.28821","article-title":"Impact of different ectopic fat depots on cardiovascular and metabolic diseases","volume":"234","author":"Ferrara","year":"2019","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.numecd.2023.07.010_bib41","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41586-018-0522-3","article-title":"Mechanosensing by \u03b21 integrin induces angiocrine signals for liver growth and survival","volume":"562","author":"Lorenz","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.numecd.2023.07.010_bib42","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jhep.2017.09.021","article-title":"Hypertension, diabetes, atherosclerosis and NASH: cause or consequence?","volume":"68","author":"Lonardo","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.numecd.2023.07.010_bib43","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrneph.2016.145","article-title":"The impact of insulin resistance on the kidney and vasculature","volume":"12","author":"Artunc","year":"2016","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.numecd.2023.07.010_bib44","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1111\/j.1478-3231.2009.01988.x","article-title":"Association between angiotensin II type 1 receptor polymorphisms and the occurrence of nonalcoholic fatty liver disease","volume":"29","author":"Yoneda","year":"2009","journal-title":"Liver Int"},{"key":"10.1016\/j.numecd.2023.07.010_bib45","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.jhep.2019.01.035","article-title":"The degree of hepatic steatosis associates with impaired cardiac and autonomic function","volume":"70","author":"Houghton","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.numecd.2023.07.010_bib46","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1161\/CIRCULATIONAHA.108.824730","article-title":"Sympathoexcitation by oxidative stress in the brain mediates arterial pressure elevation in obesity-induced hypertension","volume":"119","author":"Nagae","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2023.07.010_bib47","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.numecd.2014.10.002","article-title":"Non-alcoholic fatty liver disease is associated with progression of arterial stiffness","volume":"25","author":"Li","year":"2015","journal-title":"Nutr Metabol Cardiovasc Dis"},{"key":"10.1016\/j.numecd.2023.07.010_bib48","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1056\/NEJMoa1803180","article-title":"Effect of systolic and diastolic blood pressure on cardiovascular outcomes","volume":"381","author":"Flint","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.numecd.2023.07.010_bib49","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1001\/jama.287.20.2677","article-title":"MRFIT research group. Pulse pressure and cardiovascular disease-related mortality: follow-up study of the multiple risk factor intervention trial (MRFIT)","volume":"287","author":"Domanski","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.numecd.2023.07.010_bib50","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1161\/01.CIR.0000157159.39889.EC","article-title":"Predictors of new-onset diastolic and systolic hypertension: the Framingham Heart Study","volume":"111","author":"Franklin","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2023.07.010_bib51","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1161\/ATVBAHA.114.305200","article-title":"Nonalcoholic fatty liver disease and vascular function: cross-sectional analysis in the framingham heart study","volume":"35","author":"Long","year":"2015","journal-title":"ATVB"},{"key":"10.1016\/j.numecd.2023.07.010_bib52","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1161\/HYPERTENSIONAHA.120.15220","article-title":"Nonalcoholic fatty liver disease and advanced fibrosis in US adults across blood pressure categories","volume":"76","author":"Ciardullo","year":"2020","journal-title":"Hypertension"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S093947532300279X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S093947532300279X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:25:31Z","timestamp":1760545531000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S093947532300279X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":52,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S093947532300279X"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2023.07.010","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The causal associations of non-alcoholic fatty liver disease with blood pressure and the mediating effects of cardiometabolic risk factors: A Mendelian randomization study","name":"articletitle","label":"Article Title"},{"value":"Nutrition, Metabolism and Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.numecd.2023.07.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}